These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16519773)

  • 21. Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren's syndrome.
    Simmons DD; Al-Hashimi I; Haghighat N
    Quintessence Int; 2000 Mar; 31(3):196-200. PubMed ID: 11203926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients.
    Frost PM; Shirlaw PJ; Challacombe SJ; Fernandes-Naglik L; Walter JD; Ide M
    Oral Dis; 2006 Jan; 12(1):57-62. PubMed ID: 16390470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of saliva ferning test in diagnosis of Sjögren's syndrome].
    Ding L; Tang Y; Lu Q
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):174-6. PubMed ID: 11812334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity of stimulated whole saliva collection as a sialometric evaluation for diagnosing Sjögren's syndrome.
    Gotoh S; Watanabe Y; Fujibayashi T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):299-302. PubMed ID: 15716835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjogren's syndrome.
    Márton K; Boros I; Fejérdy P; Madléna M
    J Prosthet Dent; 2004 Jun; 91(6):577-81. PubMed ID: 15211301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minor salivary glands function is decreased in hyposalivation-related diseases.
    Wang Z; Li W; Hong X; Su JZ; Hua H; Peng X; Lv L; Yu GY
    Arch Oral Biol; 2016 Sep; 69():63-70. PubMed ID: 27243418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland parameters and clinical data related to the underlying disorder in patients with persisting xerostomia.
    van den Berg I; Pijpe J; Vissink A
    Eur J Oral Sci; 2007 Apr; 115(2):97-102. PubMed ID: 17451498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
    Deming FP; Al-Hashimi I; Haghighat N; Hallmon WW; Kerns DG; Abraham C; Rivera-Hidalgo F
    J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M; Ulbricht K; Schmidt RE; Witte T
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A screening test for unstimulated salivary flow measurement.
    Fontana M; Zunt S; Eckert GJ; Zero D
    Oper Dent; 2005; 30(1):3-8. PubMed ID: 15765951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation, differential diagnosis, and treatment of xerostomia.
    Daniels TE
    J Rheumatol Suppl; 2000 Dec; 61():6-10. PubMed ID: 11128701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of the clinical value of total salival flow rates].
    Wang S; Zhao Z; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Nov; 33(6):360-2. PubMed ID: 11774443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xerostomia. A common problem among the elderly.
    Bivona PL
    N Y State Dent J; 1998; 64(6):46-52. PubMed ID: 9707984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Dental Research Center an education & research project: total salivary protein concentration in patients with Sjögren's syndrome and a healthy control group.
    Jones V; Streckfus CF
    Miss Dent Assoc J; 1998; 54(2):40-1. PubMed ID: 9800564
    [No Abstract]   [Full Text] [Related]  

  • 36. Validity of screening tests for Sjögren's syndrome in ambulatory patients with chronic diseases.
    Sánchez-Guerrero J; Pérez-Dosal MR; Celis-Aguilar E; Cárdenas-Velázquez F; Soto-Rojas AE; Avila-Casado C
    J Rheumatol; 2006 May; 33(5):907-11. PubMed ID: 16541477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
    Mignogna MD; Fedele S; Lo Russo L; Lo Muzio L; Wolff A
    J Oral Pathol Med; 2005 Jan; 34(1):1-6. PubMed ID: 15610399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
    Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
    Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.
    Billings M; Dye BA; Iafolla T; Grisius M; Alevizos I
    Oral Dis; 2017 Apr; 23(3):387-394. PubMed ID: 27998016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xerostomia, hyposalivation and oral microbiota in patients using antihypertensive medications.
    Nonzee V; Manopatanakul S; Khovidhunkit SO
    J Med Assoc Thai; 2012 Jan; 95(1):96-104. PubMed ID: 22379748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.